drugset / Trial / NCT03655197

Lipidome and Microbiome Profile of the Eye in Rosacea

NCT03655197

Phase 0 Completed 30 enrolled University of California, Davis
Non-randomizedParallel-groupOpen-labelOther

Summary

The question that the investigators aim to address in this proposal is how the local lipid mediator profiles of ceramides and eicosanoids are altered in cutaneous and ocular rosacea and how antibiotics alter the lipidome. The investigators also seek to understand how the microbiome is changed in those with and without rosacea, and how the microbiome is altered in those with rosacea. Understanding how the lipidome is modulated in rosacea with antibiotic treatment will serve as the first step in targeting therapies toward directly altering the lipidome to reduce inflammation and ultimately reduce the use of antibiotics.

Timeline

Start
2017-11-02
Primary completion
2021-06-30
Completion
2021-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 100 mg